Alpha-2 Receptor Agonists Market size is poised to reach USD 3.6 Billion by the end of 2036, growing at a CAGR of 8.7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of alpha-2 receptor agonists was over USD 2.3 Billion.
This increase is due to the increased occurrence of hypertension and associated conditions. Approximately 1.28 billion persons worldwide, between the ages of 30 and 79, have hypertension, according to our study; low- and middle-income nations report the majority of instances.
Moreover, a number of metabolic illnesses have emerged globally due to the growing geriatric population and growing knowledge of behavioral and lifestyle changes. This has increased the need for specialized medications. Alpha-2 receptor agonists are becoming more and more popular as a therapeutic alternative because they can reduce blood pressure by inhibiting sympathetic activity in the brain.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?